Related Experiment Videos
Mast cell subtypes from human lung tissue: their identification, separation, and functional characteristics.
F J van Oveveld1, L A Houben, P L Bruijnzeel
1Dept. of Pulmonary Disease, State University Hospital, Utrecht, The Netherlands.
Summary
Researchers identified two distinct mast cell subtypes in human lungs. One subtype, the formalin-sensitive and alcian blue-positive (FS-AB) mast cell, plays a significant role in releasing histamine and leukotriene C4 (LTC4), crucial for chronic obstructive lung diseases.
Area of Science:
- Immunology
- Pulmonology
Background:
- The specific roles of mast cell subtypes and their mediators in chronic obstructive lung diseases (COLD) remain unclear.
- Understanding mast cell heterogeneity is crucial for elucidating COLD pathogenesis.
Purpose of the Study:
- To differentiate the functional characteristics of mast cell subtypes from human lung tissue.
- To investigate the mediator release profiles of distinct mast cell populations in response to various stimuli.
Main Methods:
- Isolation of two mast cell subtypes from human lung tissue using enzymatic digestion, centrifugal elutriation, and Percoll gradient centrifugation.
- Challenge of mast cell subtypes with anti-human IgE, propranolol, compound 48/80, and opsonized zymosan.
- Quantification of histamine and leukotriene C4 (LTC4) release.
Main Results:
- Both mast cell subtypes released histamine, but with varying amounts.
- The formalin-sensitive and alcian blue-positive (FS-AB) subtype released histamine upon challenge with opsonized zymosan and LTC4 upon anti-human IgE challenge.
- The formalin-insensitive and alcian blue-positive (FI-AB) subtype showed limited histamine release with propranolol/compound 48/80 and did not respond to opsonized zymosan or release LTC4 with anti-human IgE.
Conclusions:
- Distinct mast cell subtypes possess differential mediator release capabilities.
- The FS-AB mast cell subtype appears to be a key player in inflammatory responses relevant to COLD pathogenesis due to its mediator release profile.